Peer Review History
| Original SubmissionJanuary 2, 2025 |
|---|
|
-->PONE-D-24-60529-->-->Anemia, micronutrient deficiency, and elevated biomarkers of inflammation among women and children in two districts in the Northern Region of Ghana: A pilot study-->-->PLOS ONE Dear Dr. Adu-Afarwuah, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Although manuscript is well-written, the authors must clarify the data availability, as this concern was also raised by the reviewers. Please submit your revised manuscript by Mar 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hansani Madushika Abeywickrama, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: “This work was supported, in whole or in part, by a grant from Helen Keller International (66504-UCD-01), through support from the Bill & Melinda Gates Foundation (INV-007916), to the University of California, Davis. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information . 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: The authors state that the study areas were "randomly selected," yet they also mention selecting clusters in the Tolon district based on accessibility. This raises questions about the randomness of the selection process. The authors should provide a clear justification for this methodological choice to ensure transparency and consistency in their study design. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: N/A Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: I Don't Know ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: Thank you for the opportunity to review this manuscript. This manuscript is a valuable contribution to understanding anemia and micronutrient deficiencies in Northern Ghana. The manuscript exhibits undeniable strengths, including the robust application of generalized linear mixed models to account for clustering and comprehensive reporting of results. The authors effectively connect their findings to broader public health implications, such as fortification interventions. Specific areas for improvement: I. Major: o Address how missing venous blood samples for 29% of preschool children were handled. Were these participants excluded from analyses, or were imputation techniques applied? o It is unclear if all raw data (e.g., anonymized participant-level data) are included or easily accessible. The phrase “data will be made available three years after data collection” does not comply with the requirement for immediate availability upon publication. Ensure immediate public access to all data, or explicitly justify any restrictions and provide alternative means for researchers to access restricted data. II. Minor: o While the study compares findings to the 2017 Ghana Micronutrient Survey, it lacks statistical comparisons to determine the significance of differences. o Address potential biases introduced by this approach, particularly in densely populated or inaccessible areas. o Clusters in the Tolon district were chosen based on accessibility. Discuss how this may limit generalizability and how these biases were mitigated. o Expand on implications for policy and practice. For example, how can findings inform national micronutrient fortification programs? o Compare results to international data for broader relevance. o Emphasize actionable recommendations in the conclusion, such as advocating for specific interventions like water sanitation or fortified foods. Reviewer #2: DearAuthor; It is a well-planned study and the number of regions-cases evaluated is sufficient. The aims of the study are emphasized in detail. The results are reported in accordance with the aims. The findings are as expected. However, the results of the study will also be a guide for low-income countries. Anemia is a global problem in childhood and lactation group. It has emphasized the problems of micronutrient deficiency and anemia in this group with its results and has constructive suggestions in line with the results. Current results may guide larger studies. Best regards Reviewer #3: Paper Accepted And anyone who has conducted human research knows what enormous effort was made to gain permission to participate, as well as collect anthropometric measurements and biological samples. Minor Revisions Include limitations of Food Frequency Questionnaire (FFQ) to predict actual nutrient intake. A number of studies have shown r-values at or below 0.3 for predicting actual nutrient intake. Over the years, serving sizes of particular foods (for example fruits and vegetables) have varied. A table with serving sizes shown could be added to the paper's supplemental information. Additionally, in this study, this tool limited its questions to include fruits, vegetables, salty snacks, sweetened snacks, and sugar-sweetened beverages and did not appear to include protein sources. Based on the high level of zinc inadequacy, providing a supplemental list of protein food sources to the questionnaire would seem reasonable. Because one of the goals of the study is to determine the potential to use bouillon cubes for micronutrient distribution, it would have been helpful to see what percent of the surveyed households presently use bouillon cubes or were willing to incorporate this into their diet regularly. Location of raw data should be indicated in manuscript. 1) Is the manuscript technically sound, and do the data support the conclusions? A research study is only as good as its methods. The methods described in this study provide a thorough guide to what was done making it possible to repeat the study. This is a rigorous, with appropriate controls, replication, and sample sizes. Conclusions drawn on anemia and MND are appropriately based on the data presented. This study's methods are generally accepted as valid. The food frequency questionnaire (FFQ) is often used to estimate the nutritional adequacy of the diet. Sadly, this often used tool has a relatively low correlation coefficient when compared to a 24-hour recall and can lead to misinterpretations. A number of studies have shown r-values at or below 0.3 for predicting actual nutrient intake. 2) Has the statistical analysis been performed appropriately and rigorously? Based on data presented, it would appear that statistical data is both appropriate and rigorous. 3) Have the authors made all data underlying the findings in their manuscript fully available? The supplemental data appears to contain more analyses rather than raw data. Location of raw data should be indicated in manuscript. 4) Is the manuscript presented in an intelligible fashion and written in standard English? Manuscript is well written. 5) As a pilot study, the paper seems to be the first paper of a 2-part study. Follow-up study listed is reference 27. Benefits to Science: See comments above regarding methods. It was refreshing to see the full complement of micronutrients chosen to evaluate levels of anemia and iron deficiency, as well as inflammation indices. The use of well-established labs to analyze the samples also provides a level of confidence in appropriate laboratory technique. Discussion The discussion is the weakest part of the paper. The confusing MND information regarding relationship between FFQ and MND may well be due to the low correlation coefficient when compared to a 24-hour recall, this limitation should be included. Too often sugary and salty foods are thought to be the cause of malnutrition. My 20 years of clinical observations are that these food choices are instead the result of the nutrient inadequacies rather than the cause. Also, it might have been helpful to have water samples analyzed for micronutrients and heavy metals that could interfere with iron absorption. Bottom-line Even with the paper’s limitations, the well detailed methodology is of great benefit for those planning to do human research. Reviewer #4: Researchers have found that anemia and micronutrient deficiencies are common in the Tolon and Kumbungu districts. This study looked again at these issues in lactating women (LW), women of reproductive age (WRA), and preschool children (PSC) to help test fortified bouillon cubes. They wanted to identify what factors contribute to anemia, micronutrient deficiencies, and inflammation among WRA and PSC. They also examined how often anemia occurs along with these other issues. Even though Ghana has programs to improve micronutrient intake, many WRA and PSC in these districts still face high rates of deficiencies. The researchers suggest that more strategies are needed to reduce these deficiencies in these areas and similar ones. This is a study with valuable results. All sections of the article are well-written. Below are several comments for your consideration: Comment 1: In the introduction, please define micronutrients and explain which factors are considered to be micronutrients. Additionally, clarify why you selected certain micronutrients over others for this study. Comment 2: At the end of the introduction, is the following sentence accurate? (Whether the co-occurrence of anemia with MNDs or inflammation significantly contributed to anemia prevalence.) Comment 3: Discussion section, line 483: The high prevalence of anemia and MNDs among WRA and PSC in this study is consistent with data from other low- and middle-income countries. Besides addressing low- and middle-income countries, compare your results with those of similar studies conducted in high-income countries. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .--> Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.--> |
| Revision 1 |
|
Anemia, micronutrient deficiency, and elevated biomarkers of inflammation among women and children in two districts in the Northern Region of Ghana: A pilot study PONE-D-24-60529R1 Dear Dr. Adu-Afarwuah, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hansani Madushika Abeywickrama, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #3: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #3: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #3: Yes ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #3: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #3: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #3: The revisions made were thoughtful and thorough and added greatly to the manuscript. This study is a great example of researcher and institution collaborations resulting in effective research. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .--> Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-24-60529R1 PLOS ONE Dear Dr. Adu-Afarwuah, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hansani Madushika Abeywickrama Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .